Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T13:35:22.913Z.
Calculation as of: 2026-10-06T13:35:22.913Z.
Quote observation: 2026-10-06T13:35:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6f641a2bf51a69a6e8cdb13afe7e76557325a462d28890c99da58f5868e3b8e6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2017-05-04.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$1.89B
EV/FCF Ratio
N/A
TTM Avg
539.27x
3Y Avg
437.29x
5Y Avg
621.70x
Market Cap
$1.85B
EV/FCF Ratio
27.28x
TTM Avg
33.52x
3Y Avg
48.28x
5Y Avg
46.71x
Market Cap
$1.84B
EV/FCF Ratio
15.27x
TTM Avg
17.23x
3Y Avg
28.18x
5Y Avg
30.02x
Market Cap
$1.97B
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.00B
EV/FCF Ratio
762.88x
TTM Avg
495.80x
3Y Avg
11749.41x
5Y Avg
11749.41x
Market Cap
$1.72B
EV/FCF Ratio
N/A
TTM Avg
126.26x
3Y Avg
66.65x
5Y Avg
66.65x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agios Pharmaceuticals, Inc. (AGIO) | $1.85B | N/A | N/A | N/A | N/A |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | N/A | 539.27x | 437.29x | 621.70x |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.85B | 27.28x | 33.52x | 48.28x | 46.71x |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 15.27x | 17.23x | 28.18x | 30.02x |
| Generate Biomedicines, Inc. (GENB)vs › | $1.79B | N/A | N/A | N/A | N/A |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.97B | N/A | N/A | N/A | N/A |
| Absci Corporation (ABSI)vs › | $1.99B | N/A | N/A | N/A | N/A |
| AxoGen, Inc. (AXGN)vs › | $2.00B | 762.88x | 495.80x | 11749.41x | 11749.41x |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.72B | N/A | 126.26x | 66.65x | 66.65x |
| Azenta, Inc. (AZTA)vs › | $2.01B | 189.89x | 49.00x | 83.04x | 82.00x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2017-05-04 | 49.46x |
| 2017-05-03 | 48.76x |
| 2017-05-02 | 49.36x |
| 2017-05-01 | 55.24x |
| 2017-04-28 | 53.05x |
| 2017-04-27 | 54.81x |
| 2017-04-26 | 54.23x |
| 2017-04-25 | 53.77x |
| 2017-04-24 | 49.61x |
| 2017-04-21 | 49.05x |
| 2017-04-20 | 50.95x |
| 2017-04-19 | 51.63x |
| 2017-04-18 | 54.01x |
| 2017-04-17 | 61.58x |
| 2017-04-13 | 61.31x |
| 2017-04-12 | 58.83x |
| 2017-04-11 | 58.83x |
| 2017-04-10 | 58.93x |
| 2017-04-07 | 59.12x |
| 2017-04-06 | 58.90x |
| 2017-04-05 | 58.55x |
| 2017-04-04 | 61.67x |
| 2017-04-03 | 62.59x |
| 2017-03-31 | 65.83x |
| 2017-03-30 | 64.27x |
| 2017-03-29 | 64.06x |
| 2017-03-28 | 62.78x |
| 2017-03-27 | 63.43x |
| 2017-03-24 | 61.22x |
| 2017-03-23 | 59.55x |
| 2017-03-22 | 57.77x |
| 2017-03-21 | 58.11x |
| 2017-03-20 | 62.53x |
| 2017-03-17 | 58.86x |
| 2017-03-16 | 59.49x |
| 2017-03-15 | 59.72x |
| 2017-03-14 | 55.64x |
| 2017-03-13 | 56.08x |
| 2017-03-10 | 56.77x |
| 2017-03-09 | 56.08x |
| 2017-03-08 | 55.09x |
| 2017-03-07 | 52.85x |
| 2017-03-06 | 53.37x |
| 2017-03-03 | 54.89x |
| 2017-03-02 | 54.99x |
| 2017-03-01 | 56.04x |
| 2017-02-28 | 51.18x |
| 2017-02-27 | 54.01x |
| 2017-02-24 | 50.27x |
| 2017-02-23 | 49.66x |
| 2017-02-22 | 51.99x |
| 2017-02-21 | 54.07x |
| 2017-02-17 | 59.49x |
| 2017-02-16 | 33.80x |
| 2017-02-15 | 30.85x |
| 2017-02-14 | 31.06x |
| 2017-02-13 | 31.13x |
| 2017-02-10 | 31.06x |
| 2017-02-09 | 30.76x |
| 2017-02-08 | 29.41x |
| 2017-02-07 | 29.50x |
| 2017-02-06 | 29.49x |
| 2017-02-03 | 29.08x |
| 2017-02-02 | 28.76x |
| 2017-02-01 | 28.55x |
| 2017-01-31 | 28.39x |
| 2017-01-30 | 26.38x |
| 2017-01-27 | 26.96x |
| 2017-01-26 | 26.60x |
| 2017-01-25 | 27.15x |
| 2017-01-24 | 26.51x |
| 2017-01-23 | 26.78x |
| 2017-01-20 | 27.79x |
| 2017-01-19 | 27.59x |
| 2017-01-18 | 28.10x |
| 2017-01-17 | 27.02x |
| 2017-01-13 | 27.21x |
| 2017-01-12 | 27.25x |
| 2017-01-11 | 26.42x |
| 2017-01-10 | 27.77x |
| 2017-01-09 | 28.19x |
| 2017-01-06 | 31.95x |
| 2017-01-05 | 30.77x |
| 2017-01-04 | 30.51x |
| 2017-01-03 | 28.54x |
| 2016-12-30 | 27.35x |
| 2016-12-29 | 28.11x |
| 2016-12-28 | 27.90x |
| 2016-12-27 | 28.66x |
| 2016-12-23 | 28.48x |
| 2016-12-22 | 27.06x |
| 2016-12-21 | 28.66x |
| 2016-12-20 | 31.02x |
| 2016-12-19 | 30.78x |
| 2016-12-16 | 30.02x |
| 2016-12-15 | 38.67x |
| 2016-12-14 | 36.42x |
| 2016-12-13 | 35.82x |
| 2016-12-12 | 33.87x |
| 2016-12-09 | 33.61x |
| 2016-12-08 | 32.23x |
| 2016-12-07 | 31.33x |
| 2016-12-06 | 32.86x |
| 2016-12-05 | 33.84x |
| 2016-12-02 | 39.49x |
| 2016-12-01 | 40.36x |
| 2016-11-30 | 40.48x |
| 2016-11-29 | 43.00x |
| 2016-11-28 | 42.63x |
| 2016-11-25 | 44.83x |
| 2016-11-23 | 44.96x |
| 2016-11-22 | 43.39x |
| 2016-11-21 | 45.51x |
| 2016-11-18 | 43.93x |
| 2016-11-17 | 44.15x |
| 2016-11-16 | 43.45x |
| 2016-11-15 | 47.69x |
| 2016-11-14 | 47.47x |
| 2016-11-11 | 45.27x |
| 2016-11-10 | 44.91x |
| 2016-11-09 | 41.51x |
| 2016-11-08 | 37.15x |
| 2016-11-07 | 35.76x |
| 2016-11-04 | 33.51x |
| 2016-11-03 | 17.82x |
| 2016-11-02 | 17.02x |
| 2016-11-01 | 18.16x |
| 2016-10-31 | 17.93x |
| 2016-10-28 | 18.31x |
| 2016-10-27 | 18.17x |
| 2016-10-26 | 18.39x |
| 2016-10-25 | 18.39x |
| 2016-10-24 | 18.54x |
| 2016-10-21 | 18.59x |
| 2016-10-20 | 19.23x |
| 2016-10-19 | 18.18x |
| 2016-10-18 | 18.67x |
| 2016-10-17 | 17.76x |
| 2016-10-14 | 17.89x |
| 2016-10-13 | 19.43x |
| 2016-10-12 | 19.29x |
| 2016-10-11 | 20.75x |
| 2016-10-10 | 21.67x |
| 2016-10-07 | 20.46x |
| 2016-10-06 | 21.04x |
| 2016-10-05 | 21.35x |
| 2016-10-04 | 20.78x |
| 2016-10-03 | 20.54x |
| 2016-09-30 | 20.53x |
| 2016-09-29 | 20.00x |
| 2016-09-28 | 21.25x |
| 2016-09-27 | 21.43x |
| 2016-09-26 | 20.46x |
| 2016-09-23 | 20.63x |
| 2016-09-22 | 20.63x |
| 2016-09-21 | 20.25x |
| 2016-09-20 | 18.96x |
| 2016-09-19 | 17.78x |
| 2016-09-16 | 17.29x |
| 2016-09-15 | 16.91x |
| 2016-09-14 | 16.58x |
| 2016-09-13 | 16.94x |
| 2016-09-12 | 16.86x |
| 2016-09-09 | 15.40x |
| 2016-09-08 | 17.31x |
| 2016-09-07 | 17.48x |
| 2016-09-06 | 12.43x |
| 2016-09-02 | 11.93x |
| 2016-09-01 | 12.13x |
| 2016-08-31 | 12.18x |
| 2016-08-30 | 12.07x |
| 2016-08-29 | 12.66x |
| 2016-08-26 | 12.81x |
| 2016-08-25 | 12.83x |
| 2016-08-24 | 13.06x |
| 2016-08-23 | 14.35x |
| 2016-08-22 | 14.00x |
| 2016-08-19 | 13.78x |
| 2016-08-18 | 14.12x |
| 2016-08-17 | 13.79x |
| 2016-08-16 | 14.26x |
| 2016-08-15 | 14.68x |
| 2016-08-12 | 14.05x |
| 2016-08-11 | 13.80x |
| 2016-08-10 | 13.78x |
| 2016-08-09 | 14.33x |